DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Rossari Biotech Limited — Press Release

NSE 1 hr ago·18 Oct 2026, 7:17 pm

Rossari Biotech

Rossari Biotech Limited has filed a press release with the stock exchange announcing its Q2 FY27 earnings, providing the latest snapshot of the company's financial performance.

For investors, quarterly results are a key gauge of revenue growth, profit margins and the progress of its biotech product pipeline. Any material deviation from market expectations can influence sentiment and the stock’s short‑term movement.

Going forward, market participants will watch for trends in sales, any guidance for the next quarter, and updates on major contracts or regulatory approvals. Subsequent filings or analyst commentary will likely add further context.